Vybrique is an oral film formulation of sildenafil, a phosphodiesterate-5 inhibitor, designed to dissolve on the tongue without the need for food or water.
In today’s Pharmaceutical Executive Daily, FDA approves Vybrique for erectile dysfunction, experts argue Phase III clinical ...
FDA has approved Vybrique, the first oral film formulation of sildenafil for the treatment of erectile dysfunction, offering ...
An informational overview examining category context, publicly available service disclosures, and what consumers often ...
Sexual dysfunction is a reality for many women, but the subject remains taboo. A large percentage of women remain untreated, a problem that is exacerbated by the shortage of treatment options for ...
News Medical on MSN
Digital therapy significantly improves sexual function in women
Sexual dysfunction is a reality for many women, but the subject remains taboo. A large percentage of women remain untreated, a problem that is exacerbated by the shortage of treatment options for ...
An experimental therapy known as low-intensity shock wave treatment might improve erectile dysfunction, particularly for men with only mild to moderate sexual difficulties, a research review suggests.
In some people with kidney stones, low-intensity shockwave therapy (LIST) breaks them up. And in some with heart disease and fractures, LIST coaxes the body to produce new blood vessels that help with ...
The FDA issued a recall Wednesday for a honey energy supplement after an undeclared erectile dysfunction medication was found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results